Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07772401 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

Study acronym: taVNS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 30 days later Sep 1, 2026 → Oct 1, 2026
Enrollment reduced 50% 100 → 50 participants
See other at-risk trials from Second Affiliated Hospital, Zhejiang University, School of Medicine

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 100 → 50 participants
    • Primary completion pushed from Sep 1, 2026 to Oct 1, 2026
    • Eligibility criteria shortened, about 14 words
    • Secondary endpoints: 4 to 10
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with social anxiety disorder (SAD). The study addresses the following key research questions: * Does taVNS demonstrate preliminary clinical efficacy in the treatment of SAD? * What adverse events may occur during taVNS treatment, and what is the treatment compliance of the subjects?
Trial Details
NCT Number NCT07772401
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions
(from sponsor)		 Social Anxiety Disorder, Social Fear
Related terms Phobia, Social
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov